{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:50:11Z","timestamp":1789699811835,"version":"4.0.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Anaesthesiol Clin Pharmacol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/0970-9185.222511","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T07:13:09Z","timestamp":1644909189000},"page":"441","source":"Crossref","is-referenced-by-count":17,"title":["The role of neurokinin-1 (substance P) antagonists in the prevention of postoperative nausea and vomiting"],"prefix":"10.4103","volume":"33","author":[{"given":"RichardD","family":"Urman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionne","family":"Okafor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AlanDavid","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RachelJ","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0970-9185.222511-1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/bja\/aes233","article-title":"Randomized, double-blind comparison of oral aprepitant alone compared with aprepitant and transdermal scopolamine for prevention of postoperative nausea and vomiting","author":"Green","year":"2012","journal-title":"Br J Anaesth"},{"key":"key-10.4103\/0970-9185.222511-2","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s40265-013-0110-7","article-title":"Update on the management of postoperative nausea and vomiting","author":"Kovac","year":"2013","journal-title":"Drugs"},{"key":"key-10.4103\/0970-9185.222511-3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1213\/ANE.0000000000000002","article-title":"Consensus guidelines for the management of postoperative nausea and vomiting","author":"Gan","year":"2014","journal-title":"Anesth Analg"},{"key":"key-10.4103\/0970-9185.222511-4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/00000542-200004000-00012","article-title":"Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo","author":"Hill","year":"2000","journal-title":"Anesthesiology"},{"key":"key-10.4103\/0970-9185.222511-5","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1001\/jama.1989.03430210050028","article-title":"Unanticipated admission to the hospital following ambulatory surgery","author":"Gold","year":"1989","journal-title":"JAMA"},{"key":"key-10.4103\/0970-9185.222511-6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-2044.2008.05438.x","article-title":"Paediatric day-case surgery: An audit of unplanned hospital admission royal hospital for sick children, Glasgow","author":"Blacoe","year":"2008","journal-title":"Anaesthesia"},{"key":"key-10.4103\/0970-9185.222511-7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF00365579","article-title":"Treatment of chemotherapy-induced emesis in the 1990s: Impact of the 5-HT3 receptor antagonists","author":"Hesketh","year":"1994","journal-title":"Support Care Cancer"},{"key":"key-10.4103\/0970-9185.222511-8","first-page":"1055","article-title":"Patient perceptions of the side-effects of chemotherapy: The influence of 5HT3 antagonists","author":"de","year":"1997","journal-title":"Br J Cancer"},{"key":"key-10.4103\/0970-9185.222511-9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/oxfordjournals.annonc.a010548","article-title":"On the receiving end.V: Patient perceptions of the side effects of cancer chemotherapy in 1993","author":"Griffin","year":"1996","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0970-9185.222511-10","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00520-015-2856-9","article-title":"Comparison between 5-day aprepitant and single-dose fosaprepitant meglumine for preventing nausea and vomiting induced by cisplatin-based chemotherapy","author":"Ando","year":"2016","journal-title":"Support Care Cancer"},{"key":"key-10.4103\/0970-9185.222511-11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1200\/JCO.1997.15.1.103","article-title":"Proposal for classifying the acute emetogenicity of cancer chemotherapy","author":"Hesketh","year":"1997","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0970-9185.222511-12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2165\/00003495-199652050-00002","article-title":"Drug treatment of chemotherapy-induced delayed emesis","author":"Tavorath","year":"1996","journal-title":"Drugs"},{"key":"key-10.4103\/0970-9185.222511-13","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1200\/JCO.1999.17.9.2971","article-title":"Recommendations for the use of antiemetics: Evidence-based, clinical practice guidelines.American Society of Clinical Oncology","author":"Gralla","year":"1999","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0970-9185.222511-14","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","article-title":"Antiemetics: American Society of Clinical Oncology clinical practice guideline update","author":"Basch","year":"2011","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0970-9185.222511-15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/iju.12870","article-title":"Editorial Comment to Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine\/cisplatin in urothelial cancer patients","author":"Rozzi","year":"2015","journal-title":"Int J Urol"},{"key":"key-10.4103\/0970-9185.222511-16","first-page":"387","article-title":"Palonsetron hydrochloride in the prevention and treatment of postoperative nausea and vomiting","author":"Wallenborn","year":"2010","journal-title":"Clin Med Insights Ther"},{"key":"key-10.4103\/0970-9185.222511-17","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00540-012-1529-9","article-title":"Oral administration of aprepitant to prevent postoperative nausea in highly susceptible patients after gynecological laparoscopy","author":"Jung","year":"2013","journal-title":"J Anesth"},{"key":"key-10.4103\/0970-9185.222511-18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4097\/kjae.2013.64.3.212","article-title":"Efficacy of the oral neurokinin-1 receptor antagonist aprepitant administered with ondansetron for the prevention of postoperative nausea and vomiting","author":"Lim","year":"2013","journal-title":"Korean J Anesthesiol"},{"key":"key-10.4103\/0970-9185.222511-19","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/00000542-200010000-00009","article-title":"Substance P (neurokinin-1) antagonist prevents postoperative vomiting after abdominal hysterectomy procedures","author":"Gesztesi","year":"2000","journal-title":"Anesthesiology"},{"key":"key-10.4103\/0970-9185.222511-20","doi-asserted-by":"crossref","first-page":"e762","DOI":"10.1097\/MD.0000000000000762","article-title":"Neurokinin-1 receptor antagonists in preventing postoperative nausea and vomiting: A systematic review and meta-analysis","author":"Liu","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"key-10.4103\/0970-9185.222511-21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2885.2008.00991.x","article-title":"Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs","author":"Sedlacek","year":"2008","journal-title":"J Vet Pharmacol Ther"},{"key":"key-10.4103\/0970-9185.222511-22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/bja\/aep125","article-title":"Neurokinin-1 receptor antagonists in the prevention of postoperative nausea and vomiting","author":"Diemunsch","year":"2009","journal-title":"Br J Anaesth"},{"key":"key-10.4103\/0970-9185.222511-23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1476-5381.1995.tb16324.x","article-title":"The anti-emetic effects of CP-99,994 in the ferret and the dog: Role of the NK1 receptor","author":"Watson","year":"1995","journal-title":"Br J Pharmacol"},{"key":"key-10.4103\/0970-9185.222511-24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1152\/physrev.1993.73.2.229","article-title":"Neurotransmitter functions of mammalian tachykinins","author":"Otsuka","year":"1993","journal-title":"Physiol Rev"},{"key":"key-10.4103\/0970-9185.222511-25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2165\/00003495-200060030-00002","article-title":"Potential of substance P antagonists as antiemetics","author":"Diemunsch","year":"2000","journal-title":"Drugs"},{"key":"key-10.4103\/0970-9185.222511-26","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1124\/dmd.108.021758","article-title":"Pharmacokinetics and brain penetration of casopitant, a potent and selective neurokinin-1 receptor antagonist, in the ferret","author":"Minthorn","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"key-10.4103\/0970-9185.222511-27","first-page":"1280","article-title":"Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting: A systematic review","author":"dos","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/0970-9185.222511-28","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4097\/kjae.2013.64.3.212","article-title":"Efficacy of the oral neurokinin-1 receptor antagonist aprepitant administered with ondansetron for the prevention of postoperative nausea and vomiting","author":"Lim","year":"2013","journal-title":"Korean J Anesthesiol"},{"key":"key-10.4103\/0970-9185.222511-29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/bja\/aem133","article-title":"Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: A randomized, double-blind phase III trial in patients undergoing open abdominal surgery","author":"Diemunsch","year":"2007","journal-title":"Br J Anaesth"},{"key":"key-10.4103\/0970-9185.222511-30","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1093\/annonc\/mdq149","article-title":"Aprepitant: Drug-drug interactions in perspective","author":"Aapro","year":"2010","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0970-9185.222511-31","unstructured":"Emend\u00ae [Product Information], Whitehouse Station, New Jersey: Merck & Co., Inc.; August, 2014. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/022023s011lbl.pdf. [Last Accessed on 2015 Oct 22]."},{"key":"key-10.4103\/0970-9185.222511-32","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s00540-015-2054-4","article-title":"The effects of intravenous fosaprepitant and ondansetron in the prevention of postoperative nausea and vomiting in patients who underwent lower limb surgery: A prospective, randomized, double-blind study","author":"Kakuta","year":"2015","journal-title":"J Anesth"},{"key":"key-10.4103\/0970-9185.222511-33","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00540-015-2006-z","article-title":"Fosaprepitant versus ondansetron for the prevention of postoperative nausea and vomiting in patients who undergo gynecologic abdominal surgery with patient-controlled epidural analgesia: A prospective, randomized, double-blind study","author":"Soga","year":"2015","journal-title":"J Anesth"},{"key":"key-10.4103\/0970-9185.222511-34","first-page":"307025","article-title":"The effects of intravenous fosaprepitant and ondansetron for the prevention of postoperative nausea and vomiting in neurosurgery patients: A prospective, randomized, double-blinded study","author":"Tsutsumi","year":"2014","journal-title":"Biomed Res Int"},{"key":"key-10.4103\/0970-9185.222511-35","unstructured":"Emend\u00ae [Patient Information], Whitehouse Station, New Jersey: Merck & Co., Inc.; December, 2015. Available from: http:\/\/www.merck.com\/product\/usa\/pi_circulars\/e\/emend\/emend_ppi.pdf. [Last accessed on 2016 Jan 11]."},{"key":"key-10.4103\/0970-9185.222511-36","first-page":"762","article-title":"Treatment of postoperative nausea and vomiting","author":"Messori","year":"2003","journal-title":"BMJ"},{"key":"key-10.4103\/0970-9185.222511-37","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1185\/030079907X233115","article-title":"Preventing postoperative nausea and vomiting: Post hoc analysis of pooled data from two randomized active-controlled trials of aprepitant","author":"Diemunsch","year":"2007","journal-title":"Curr Med Res Opin"}],"container-title":["Journal of Anaesthesiology Clinical Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:27:48Z","timestamp":1787164068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0970-9185.222511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"alternative-id":["222511"],"URL":"https:\/\/doi.org\/10.4103\/0970-9185.222511","relation":{},"ISSN":["0970-9185"],"issn-type":[{"value":"0970-9185","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}